
| 4 min read
Alzheimer’s diagnosis tests, AI-designed DNA circuits, bacterial insights, and more led the news this week. 
| 5 min read
While faster reviews could bring life-saving treatments to patients sooner, compressed timelines could also limit regulatory scrutiny and strain FDA resources.
| 4 min read
LYMPHIR delivers targeted therapy for a rare and incurable form of skin lymphoma while opening doors for broader immuno-oncology applications.
| 4 min read
Combining unified data architecture with standards-based hardware allows pharma companies to scale processes faster and more reliably.News
Cancer Research News
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures.
Phase 2 trial shows that a topical drug rapidly reduces malodor, pain, and improves quality of life for patients with malignant fungating wounds.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Can animal testing be replaced? Discover how scientists are developing more human-relevant ways to predict drug toxicity earlier.
Learn about common challenges and proper maintenance practices for catheterized rodent models.



















